Xcout Intel
Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a biopharmaceutical company that advances early-stage pharmaceutical research and development by taking promising drugs through pre-clinical and clinical testing. The company focuses on creating therapeutic treatments across multiple medical areas, including oncology, neurology, inflammatory conditions, and dermatology, with the goal of improving patient quality of life.
Subscribe to see Hoth Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Hoth Therapeutics, Inc. at a glance
Hoth Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $33.7M across the 6 funding rounds on record. Its most recent funding round raised $10M in January 2023. Xcout tracks 3 named people at Hoth Therapeutics, Inc., including David Briones (Chief Financial Officer).
Hoth Therapeutics, Inc. leadership
- David BrionesChief Financial Officer
- Robb KnieFounder, President, and Chief Executive Officer
- Hayley SpringerExecutive Vice President Operations
Hoth Therapeutics, Inc. funding rounds
At least $33.7M raised across the 6 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $10M | — | |
| SEC Form D filing | $15M | — | |
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $2M | — | |
| SEC Form D filing | $1M | — | |
| SEC Form D filing | $675,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hoth Therapeutics, Inc. competitors
A few of Hoth Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Neotx Holdings Ltd. is a biopharmaceutical company that develops cancer therapeutics and immunotherapies. It conducts clinical trials and researches proprietary technologies aimed at advancing cancer treatment.
Radar Therapeutics, Inc. is a United States-based holding and biotechnology company located in California that focuses on drug pipelines and therapeutic innovations.
Soteria Biotherapeutics, Inc. is a biopharmaceutical company founded in 2018 and headquartered in San Francisco, California, specializing in biopharmaceutical advancements and drug pipelines.
Pinteon Therapeutics, Inc. is a clinical-stage biotechnology and holding company focused on developing targeted therapeutics and drug pipelines.
Halia Therapeutics, Inc. is a clinical-stage biotechnology research company focused on discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and other diseases. The company is actively advancing global clinical programs and is headquartered in Lehi, Utah.
St. James Therapeutics is a clinical-stage biopharmaceutical company that develops specialized topical skincare products to treat chemotherapy-induced side effects, specifically hand-foot syndrome. The company serves cancer patients by creating science-backed solutions designed to make cancer treatment more tolerable.
Get Hoth Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Hoth Therapeutics, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Hoth Therapeutics, Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 6 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access